Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Barazzoni, Rocco ^a   Aleksova, Aneta ^a   Carriere, Cosimo ^a   Cattin, Maria R ^a   Zanetti, Michela ^a   Vinci, Pierandrea ^a   Stolfo, Davide ^a   Guarnieri, Gianfranco ^a   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Acute coronary syndrome; Obesity; Pentraxin 3

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE; INSULIN; PENTRAXIN 3;

ABDOMINAL FAT; ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; SERUM AMYLOID P-COMPONENT; WAIST CIRCUMFERENCE;

EID: 84887392594     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-167     Document Type: Article

References (24)

1. Garlanda C, Bottazzi B, Moalli F, Deban L, Molla F, Latini R, Mantovani A. Pentraxins and atherosclerosis: the role of PTX3. Curr Pharm Des 2011, 17:38-46. 10.2174/138161211795049750, 21226667.
2. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 2010, 20:35-40. 10.1016/j.tcm.2010.03.005, 20656213.
3. Huang JW, Yang CY, Wu HY, Liu KL, Su CT, Wu CK, Lee JK, Chiang CK, Cheng HT, Lien YC, Hung KY. Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients. Cardiovasc Diabetol 2013, 12:86. 10.1186/1475-2840-12-86, 3695854, 23758640.
4. Miyaki A, Maeda S, Choi Y, Akazawa N, Eto M, Tanaka K, Ajisaka R. Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals. Am J Hypertens 2013, 26:1250-1255. 10.1093/ajh/hpt103, 23771016.
5. Zanetti M, Bosutti A, Ferreira C, Vinci P, Biolo G, Fonda M, Valente M, Cattin L, Guarnieri G, Barazzoni R. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med 2009, 9:243-248. 10.1007/s10238-009-0039-z, 19238513.
6. Koga S, Ikeda S, Yoshida T, Nakata T, Takeno M, Masuda N, Koide Y, Kawano H, Maemura K. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound. JACC Cardiovasc Interv 2013, 6:945-954. 10.1016/j.jcin.2013.04.024, 23954061.
7. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, Pizzetti F, Maggioni AP, Moccetti T, Metra M, Cas LD, Ghezzi P, Sipe JD, Re G, Olivetti G, Mantovani A, Latini R. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000, 102:636-641. 10.1161/01.CIR.102.6.636, 10931803.
8. Eggers KM, Armstrong PW, Califf RM, Johnston N, Simoons ML, Venge P, James SK. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome. Clin Biochem 2013, doi: 10.1016/j.clinbiochem.2013.08.014.
9. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Lipid Assessment Trial Italian Network (LATIN) Investigators Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004, 110:2349-2354. 10.1161/01.CIR.0000145167.30987.2E, 15477419, Lipid Assessment Trial Italian Network (LATIN) Investigators.
10. Matsui S, Ishii J, Kitagawa F, Kuno A, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Naruse H, Tanaka I, Nomura M, Hishida H, Ozaki Y. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 2010, 210:220-225. 10.1016/j.atherosclerosis.2009.10.033, 19945702.
11. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Negoita M, Lansky AJ, Mehran R. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 2006, 151:168-175. 10.1016/j.ahj.2005.03.024, 16368312.
12. Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, Werner KD, Schindler C, Neumann FJ. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007, 28:1694-1701. 10.1093/eurheartj/ehm220, 17576661.
13. Osorio-Conles O, Guitart M, Chacón MR, Maymo-Masip E, Moreno-Navarrete JM, Montori-Grau M, Näf S, Fernandez-Real JM, Vendrell J, Gómez-Foix AM. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity. Am J Physiol Endocrinol Metab 2011, 301:E1254-E1261. 10.1152/ajpendo.00163.2011, 21900125.
14. Suliman ME, Qureshi AR, Carrero JJ, Bárány P, Yilmaz MI, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. QJM 2008, 101:397-405. 10.1093/qjmed/hcn019, 18292098.
15. Miyamoto T, Rashid Qureshi A, Heimbürger O, Bárány P, Carrero K, Sjöberg B, Lindholm B, Stenvinkel P, Carrero JJ. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. Clin J Am Soc Nephrol 2011, 6:2785-2791. 10.2215/CJN.02320311, 3255358, 22157708.
16. Ogawa T, Kawano Y, Imamura T, Kawakita K, Sagara M, Matsuo T, Kakitsubata Y, Ishikawa T, Kitamura K, Hatakeyama K, Asada Y, Kodama T. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome. Obesity 2010, 18:1871-1874. 10.1038/oby.2009.507, 20111016.
17. Yamasaki K, Kurimura M, Kasai T, Sagara M, Kodama T, Inoue K. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med 2009, 47:471-477.
18. Chu SH, Park JH, Lee MK, Jekal Y, Ahn KY, Chung JY, Lee DH, Kim ES, Naruse M, Im JA, Kong ID, Chung CH, Lee JW, Chung KM, Kim YB, Jeon JY. The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention. Clin Chim Acta 2012, 413:1430-1437. 10.1016/j.cca.2012.06.002, 22687644.
19. Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2012, 28:722-725. 10.3109/09513590.2011.652719, 22304663.
20. Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, Bonino F, Moustaid-Moussa N, Pasqualini F, Mantovani A, Ailhaud G, Amri EZ. Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res 2003, 44:994-1000. 10.1194/jlr.M200382-JLR200, 12611905.
21. Alberti L, Gilardini L, Zulian A, Micheletto G, Peri G, Doni A, Mantovani A, Invitti C. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis 2009, 202:455-460. 10.1016/j.atherosclerosis.2008.05.015, 18571180.
22. Barazzoni R, Aleksova A, Armellini I, Cattin MR, Zanetti M, Carriere C, Giacca M, Dore F, Guarnieri G, Sinagra G. Adipokines, ghrelin and obesity-associated insulin resistance in nondiabetic patients with acute coronary syndrome. Obesity 2012, 20:2348-2353. 10.1038/oby.2012.121, 22653312.
23. Salio M, Chimenti S, De Angelis N, Molla F, Maina V, Nebuloni M, Pasqualini F, Latini R, Garlanda C, Mantovani A. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008, 117:1055-1064. 10.1161/CIRCULATIONAHA.107.749234, 18268142.
24. Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009, 120:699-708. 10.1161/CIRCULATIONAHA.108.806547, 19667236.